1,124 results on '"Isnard P"'
Search Results
102. Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)
- Author
-
Cecilia T Costiniuk, Jean-Pierre Routy, Bertrand Lebouché, Nicolas Chomont, Stéphane Isnard, André Marette, Nancy Sheehan, Peter L Lakatos, Talat Bessissow, Bertrand Routy, John Lin, Jing Ouyang, Marina Klein, Brandon Fombuena, Léna Royston, and Simeng Bu
- Subjects
Medicine - Published
- 2022
- Full Text
- View/download PDF
103. Frequency Properties of Polymer Bonded Compacts Obtained from Ball Milled Permalloy Powders with Mo and Cu Additions
- Author
-
Florin Popa, Olivier Isnard, Bogdan Viorel Neamțu, and Ionel Chicinaș
- Subjects
permalloy ,mechanical alloying ,nanocrystalline ,polymerization ,magnetic measurements ,Technology ,Electrical engineering. Electronics. Nuclear engineering ,TK1-9971 ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Microscopy ,QH201-278.5 ,Descriptive and experimental mechanics ,QC120-168.85 - Abstract
Nanocrystalline powders from the Permalloy family, Ni75Fe25, Ni79Fe16Mo5, and Ni77Fe14Cu5Mo4, were obtained by mechanical alloying starting from elemental powders. All compositions were milled for up to 24 h in a high-energy planetary ball mill. The powders were single phase and nanocrystalline as determined by X-ray diffraction studies, with larger flatted particle sizes for Ni75Fe25 (about 400 μm) and Ni77Fe14Cu5Mo4 (about 470 μm), and smaller particle sizes for Ni79Fe16Mo5 (about 170 μm). The homogeneity of the samples was verified by energy-dispersive X-ray spectroscopy (EDX). Soft magnetic composites were obtained by adding 3% of Araldite to the powders, followed by compaction at 700 MPa, and then polymerization. A very good powder covering by the polymer layer was proven by EDX elementals maps. The influence of composition change on the electrical resistivity of the compacts was studied. Hysteresis measurements in static and dynamic fields of up to 10 kHz were recorded, showing the influence of composition and particle size on the compact properties.
- Published
- 2023
- Full Text
- View/download PDF
104. Random errors in protein synthesis activate an age-dependent program of muscle atrophy in mice
- Author
-
Moore, James, Akbergenov, Rashid, Nigri, Martina, Isnard-Petit, Patricia, Grimm, Amandine, Seebeck, Petra, Restelli, Lisa, Frank, Stephan, Eckert, Anne, Thiam, Kader, Wolfer, David P., Shcherbakov, Dimitri, and Böttger, Erik C.
- Published
- 2021
- Full Text
- View/download PDF
105. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients
- Author
-
Malard, Florent, Vekhoff, Anne, Lapusan, Simona, Isnard, Francoise, D’incan-Corda, Evelyne, Rey, Jérôme, Saillard, Colombe, Thomas, Xavier, Ducastelle-Lepretre, Sophie, Paubelle, Etienne, Larcher, Marie-Virginie, Rocher, Clément, Recher, Christian, Tavitian, Suzanne, Bertoli, Sarah, Michallet, Anne-Sophie, Gilis, Lila, Peterlin, Pierre, Chevallier, Patrice, Nguyen, Stéphanie, Plantamura, Emilie, Boucinha, Lilia, Gasc, Cyrielle, Michallet, Mauricette, Dore, Joel, Legrand, Ollivier, and Mohty, Mohamad
- Published
- 2021
- Full Text
- View/download PDF
106. The role of hybrid FDG-PET/MRI on decision-making in presurgical evaluation of drug-resistant epilepsy
- Author
-
Tóth, Márton, Barsi, Péter, Tóth, Zoltán, Borbély, Katalin, Lückl, János, Emri, Miklós, Repa, Imre, Janszky, József, Dóczi, Tamás, Horváth, Zsolt, Halász, Péter, Juhos, Vera, Gyimesi, Csilla, Bóné, Beáta, Kuperczkó, Diána, Horváth, Réka, Nagy, Ferenc, Kelemen, Anna, Jordán, Zsófia, Újvári, Ákos, Hagiwara, Koichi, Isnard, Jean, Pál, Endre, Fekésházy, Attila, Fabó, Dániel, and Vajda, Zsolt
- Published
- 2021
- Full Text
- View/download PDF
107. Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review
- Author
-
Jiangyu Yan, Jing Ouyang, Stéphane Isnard, Xin Zhou, Vijay Harypursat, Jean-Pierre Routy, and Yaokai Chen
- Subjects
HIV ,alcohol ,gut ,microbial translocation ,chronic inflammation ,Immunologic diseases. Allergy ,RC581-607 - Abstract
The intestinal microbiome is an essential so-called human “organ”, vital for the induction of innate immunity, for metabolizing nutrients, and for maintenance of the structural integrity of the intestinal barrier. HIV infection adversely influences the richness and diversity of the intestinal microbiome, resulting in structural and functional impairment of the intestinal barrier and an increased intestinal permeability. Pathogens and metabolites may thus cross the “leaky” intestinal barrier and enter the systemic circulation, which is a significant factor accounting for the persistent underlying chronic inflammatory state present in people living with HIV (PLWH). Additionally, alcohol use and abuse has been found to be prevalent in PLWH and has been strongly associated with the incidence and progression of HIV/AIDS. Recently, converging evidence has indicated that the mechanism underlying this phenomenon is related to intestinal microbiome and barrier function through numerous pathways. Alcohol acts as a “partner” with HIV in disrupting microbiome ecology, and thus impairing of the intestinal barrier. Optimizing the microbiome and restoring the integrity of the intestinal barrier is likely to be an effective adjunctive therapeutic strategy for PLWH. We herein critically review the interplay among HIV, alcohol, and the gut barrier, thus setting the scene with regards to development of effective strategies to counteract the dysregulated gut microbiome and the reduction of microbial translocation and inflammation in PLWH.
- Published
- 2021
- Full Text
- View/download PDF
108. Glutathione Metabolism Is a Regulator of the Acute Inflammatory Response of Monocytes to (1→3)-β-D-Glucan
- Author
-
Rayoun Ramendra, Mathieu Mancini, Jose-Mauricio Ayala, Lin Tze Tung, Stephane Isnard, John Lin, Jean-Pierre Routy, Anastasia Nijnik, and David Langlais
- Subjects
B-glucan ,glutathione ,immunometabolism ,innate immunity ,host response ,Immunologic diseases. Allergy ,RC581-607 - Abstract
(1→3)-β-D-Glucan (BDG) represents a potent pathogen-associated molecular pattern (PAMP) in triggering the host response to fungal and some bacterial infections. Monocytes play a key role in recognizing BDG and governing the acute host response to infections. However, the mechanisms regulating monocyte’s acute response to BDG are poorly understood. We sought to investigate the response of monocytes to BDG at the epigenetic, transcriptomic, and molecular levels. Response of human monocytes to 1, 4, and 24 hours of BDG exposure was investigated using RNA-seq, ATAC-seq, H3K27ac and H3K4me1 ChIP-seq. We show that pathways including glutathione metabolism, pentose phosphate pathway, and citric acid cycle were upregulated at the epigenetic and transcriptomic levels in response to BDG exposure. Strikingly, unlike bacterial lipopolysaccharides, BDG induced intracellular glutathione synthesis. BDG exposure also induced NADP synthesis, increased NADPH/NADP ratio, and increased expression of genes involved in the pentose phosphate pathway in a GSH-dependent manner. By inhibiting GSH synthesis with L-buthionine sulfoximine (BSO) before BDG exposure we show that the GSH pathway promotes cell survival and regulates monocyte’s effector functions including NO production, phagocytosis, and cytokine production. In summary, our work demonstrates that BDG induces glutathione synthesis and metabolism in monocytes, which is a major promoter of the acute functional response of monocytes to infections.
- Published
- 2021
- Full Text
- View/download PDF
109. Designing a Person-Centred Integrated Care Programme for People with Complex Chronic Conditions: A Case Study from Catalonia
- Author
-
Miquel À. Mas, Ramón Miralles, Consol Heras, Maria J. Ulldemolins, Josep M. Bonet, Núria Prat, Mar Isnard, Sara Pablo, Sara Rodoreda, Joaquim Verdaguer, Magdalena Lladó, Eduard Moreno-Gabriel, Agustín Urrutia, Maria A. Rocabayera, Nemesio Moreno-Millan, Josep M. Modol, Isabel Andrés, Oriol Estrada, Jordi Ara Del Rey, and ProPCC-Badalona Group
- Subjects
integrated care ,personcentredness ,complex chronic conditions ,programme design ,multimorbidity, advanced conditions, older people ,Medicine (General) ,R5-920 - Abstract
Introduction: The prevalence of people with complex chronic conditions is increasing. This population’s high social and health needs require person-centred integrated approaches to care. Methods: To collect data about experiences with the health system and identify priorities for care, we conducted 2 focus groups and 15 semi-structured interviews involving patients with multimorbidity and advanced conditions, caregivers, and representatives of patients’ associations. To design the programme, we combined this information with evidence-based recommendations from local healthcare and social care professionals. Results: Patients’ and caregivers’ main priorities were to ensure (a) comprehension of information provided by healthcare professionals; (b) coordination between patients, caregivers, and professionals; (c) access to social services; (d) support to caregivers in managing situations; (e) perceived support throughout the healthcare process; (f) home care, when available; and (d) a patient-centred approach. These dimensions were included in 37 of 63 clinical actions of the programme to cover the whole care trajectory: identifying high needs, defining, and providing care plans, managing crises, and providing transitional care and end-of-life care. Conclusion: We developed an evidence-based integrated care programme tailored to high-need patients combining input from patients, caregivers, and healthcare and social care professionals.
- Published
- 2021
- Full Text
- View/download PDF
110. 749 A novel translational mouse model for assessment of human STING-targeting therapies
- Author
-
Gaëlle Martin, Fabiane Sônego, Audrey Beringer, Chloé Beuraud, Yacine Cherifi, Patricia Isnard-Petit, Kader Thiam, and Angela Pappalardo
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
111. 908 Humanized model for assessment of therapies targeting either lymphoid or myeloid compartment: enhanced evaluation of clinical relevancy & translatability
- Author
-
Charles Dumontet, Gaëlle Martin, Chloé Beuraud, Yacine Cherifi, Alexandre Fraichard, Patricia Isnard-Petit, Kader Thiam, Angus Sinclair, Poonam Yakkundi, Florence Renart-Depontieu, Morgane Denis, Léa Magadoux, Elsa Kress, Ludovic Bourre, Dean Campbell, and Astrid Doerner
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2021
- Full Text
- View/download PDF
112. Effect of a prospective audit with intervention and feedback on Clostridioides difficile infection management
- Author
-
Benoist, H., de La Blanchardière, A., Flatres, A., Isnard, C., Thibon, P., and Saint-Lorant, G.
- Published
- 2020
- Full Text
- View/download PDF
113. Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies
- Author
-
Peric, Zinaida, Mohty, Razan, Bastos, Juliana, Brissot, Eolia, Battipaglia, Giorgia, Belhocine, Ramdane, Sestili, Simona, Giannotti, Federica, Vekhoff, Anne, Ledraa, Tounes, Legrand, Ollivier, Lapusan, Simona, Isnard, Francoise, Labopin, Myriam, Bonnin, Agnes, Mediavilla, Clemence, Rubio, Marie-Thérèse, Ruggeri, Annalisa, Duléry, Rémy, Malard, Florent, and Mohty, Mohamad
- Published
- 2020
- Full Text
- View/download PDF
114. Predictors of Left Ventricular Dysfunction in Friedreich’s Ataxia in a 16-Year Observational Study
- Author
-
Legrand, Lise, Diallo, Abdourahmane, Monin, Marie-Lorraine, Ewenczyk, Claire, Charles, Perrine, Isnard, Richard, Vicaut, Eric, Montalescot, Gilles, Durr, Alexandra, and Pousset, Francoise
- Published
- 2020
- Full Text
- View/download PDF
115. Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
- Author
-
Debureaux, Pierre-Edouard, Labopin, Myriam, Mamez, Anne-Claire, Lapusan, Simona, Isnard, Francoise, Adaeva, Rosa, Bonnin, Agnès, Hirsch, Pierre, Delhommeau, Francois, Battipaglia, Giorgia, Duléry, Remy, Malard, Florent, Vekhoff, Anne, Mohty, Mohamad, Legrand, Ollivier, and Brissot, Eolia
- Published
- 2020
- Full Text
- View/download PDF
116. Acute kidney injury in patients treated with immune checkpoint inhibitors
- Author
-
Joe-Elie Salem, Enriqueta Felip, Sophie Papa, Shuchi Anand, Karolina Benesova, Marlies Ostermann, Ala Abudayyeh, Omar Mamlouk, Umut Selamet, Grace Cherry, Sunandana Chandra, Sandra M Herrmann, Maria Jose Soler, Abhijat Kitchlu, Jamie S Lin, Kerry L Reynolds, Osama E Rahma, Elizabeth M Gaughan, Eva Muñoz-Couselo, Jamie S Hirsch, Pablo Garcia, Meghan D Lee, Harish Seethapathy, Ian A Strohbehn, Meghan E Sise, Wei-Ting Chang, Els Wauters, Lucy Flanders, Deborah Schrag, Thibaud Koessler, Mark Eijgelsheim, Shruti Gupta, Frank B Cortazar, Samuel A P Short, Jason M Prosek, Sethu M Madhavan, Ilya Glezerman, Shveta S Motwani, Naoka Murakami, Rimda Wanchoo, David I Ortiz-Melo, Arash Rashidi, Ben Sprangers, Vikram Aggarwal, A Bilal Malik, Sebastian Loew, Christopher A Carlos, Pazit Beckerman, Zain Mithani, Chintan V Shah, Amanda D Renaghan, Sophie De Seigneux, Luca Campedel, Daniel Sanghoon Shin, Sunil Rangarajan, Priya Deshpande, Gaia Coppock, Dwight H. Owen, Marium Husain, Clara Garcia-Carro, Sheila Bermejo, Nuttha Lumlertgul, Nina Seylanova, Busra Isik, Aydin Kaghazchi, Yuriy Khanin, Sheru K Kansal, Kai M Schmidt-Ott, Raymond K Hsu, Maria C Tio, Suraj Sarvode Mothi, Harkarandeep Singh, Kenar D Jhaveri, David E Leaf, Corinne Isnard Bagnis, Suraj S Mothi, Weiting Chang, Vipulbhai Sakhiya, Daniel Stalbow, Sylvia Wu, Armando Cennamo, Anne Rigg, Nisha Shaunak, Zoe A Kibbelaar, Harish S Seethapathy, Meghan Lee, Ian A Strohbhen, Ilya G Glezerman, Dwight H Owen, Sharon Mini, Andrey Kisel, Nicole Albert, Katherine Carter, Vicki Donley, Tricia Young, Heather Cigoi, Els Wauters Ben Sprangers, Javier A Pagan, Jonathan J Hogan, Valda Page, Samuel AP Short, and Maria Josep Carreras
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has emerged as an important toxicity among patients with cancer.Methods We collected data on 429 patients with ICPi-AKI and 429 control patients who received ICPis contemporaneously but who did not develop ICPi-AKI from 30 sites in 10 countries. Multivariable logistic regression was used to identify predictors of ICPi-AKI and its recovery. A multivariable Cox model was used to estimate the effect of ICPi rechallenge versus no rechallenge on survival following ICPi-AKI.Results ICPi-AKI occurred at a median of 16 weeks (IQR 8–32) following ICPi initiation. Lower baseline estimated glomerular filtration rate, proton pump inhibitor (PPI) use, and extrarenal immune-related adverse events (irAEs) were each associated with a higher risk of ICPi-AKI. Acute tubulointerstitial nephritis was the most common lesion on kidney biopsy (125/151 biopsied patients [82.7%]). Renal recovery occurred in 276 patients (64.3%) at a median of 7 weeks (IQR 3–10) following ICPi-AKI. Treatment with corticosteroids within 14 days following ICPi-AKI diagnosis was associated with higher odds of renal recovery (adjusted OR 2.64; 95% CI 1.58 to 4.41). Among patients treated with corticosteroids, early initiation of corticosteroids (within 3 days of ICPi-AKI) was associated with a higher odds of renal recovery compared with later initiation (more than 3 days following ICPi-AKI) (adjusted OR 2.09; 95% CI 1.16 to 3.79). Of 121 patients rechallenged, 20 (16.5%) developed recurrent ICPi-AKI. There was no difference in survival among patients rechallenged versus those not rechallenged following ICPi-AKI.Conclusions Patients who developed ICPi-AKI were more likely to have impaired renal function at baseline, use a PPI, and have extrarenal irAEs. Two-thirds of patients had renal recovery following ICPi-AKI. Treatment with corticosteroids was associated with improved renal recovery.
- Published
- 2021
- Full Text
- View/download PDF
117. Magnetic-field-induced avalanches in magnetization and magnetoresistance of La0.9Ce0.1Fe12B6 compound
- Author
-
Diop, L. V. B. and Isnard, O.
- Published
- 2021
- Full Text
- View/download PDF
118. Aspectos contemporâneos da administração: análises e reflexões
- Author
-
ISNARD, P., primary
- Published
- 2021
- Full Text
- View/download PDF
119. Structural, Microstructural and Magnetic Properties of SmCo5/20wt%Fe Magnetic Nanocomposites Produced by Mechanical Milling in the Presence of CaO
- Author
-
Razvan Hirian, Rares Adrian Bortnic, Florin Popa, Gabriela Souca, Olivier Isnard, and Viorel Pop
- Subjects
mechanical milling ,hard–soft exchange-coupled nanocomposites ,spring magnet ,CaO matrix processing ,Chemistry ,QD1-999 - Abstract
In this work, we demonstrate the possibility of using a soluble ceramic material, 5 wt% CaO, as an additive for an SmCo5/20wt%Fe exchange-coupled nanocomposite obtained by mechanical milling in order to inhibit the grain growth of the soft magnetic phase during annealing, which results in a more stable microstructure and an implicit improvement in the hard–soft interphase exchange coupling. Moreover, we show that the additive improves the phase stability of the composite material, reducing the amount of Sm2Co17-type phases formed during the synthesis process, an important aspect because Sm2Co17 is detrimental to the magnetic performance of the SmCo5/20%Fe nanocomposite. These effects are reflected in a nearly 13% increase in the coercive field (Hc) and a 20% increase in the energy product, (BH)max, for the powders produced using CaO as compared to pure SmCo5/20%Fe nanocomposites processed in the same manner.
- Published
- 2022
- Full Text
- View/download PDF
120. Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment
- Author
-
John Lin, Jing Ouyang, Xiao-Rong Peng, Stéphane Isnard, Brandon Fombuena, Jean-Pierre Routy, Yao-Kai Chen, and Peng Lyu
- Subjects
Medicine - Published
- 2020
- Full Text
- View/download PDF
121. Magnetic and dielectric properties in the langasite-type compounds : A3BFe3D2O14 with A=Ba, Sr, Ca, B=Ta, Nb, Sb and D=Ge, Si
- Author
-
Marty, Karol, Bordet, Pierre, Simonet, Virginie, Loire, Mickael, Ballou, Rafik, Darie, Céline, Kljun, Jakob, Bonville, Pierre, Isnard, Olivier, Lejay, Pascal, Zawilski, Bartosz, and Simon, Charles
- Subjects
Condensed Matter - Strongly Correlated Electrons - Abstract
The Fe-based langasites are the first reported compounds presenting a magnetic ordering in this rich family, besides being well known for piezo-electric properties and optical activity. The structural, magnetic and dielectric properties of the Fe langasite compounds, with various substitution of non-magnetic cations, have been studied with x-ray and neutron diffraction, magnetostatic measurements, M\"ossbauer spectroscopy, and dielectric measurements. The title compounds (trigonal, space group P321) display a helical magnetic order with signatures of frustration below TN ~24- 35 K where an anomaly of the dielectric permittivity is observed. The influence of the cationic substitutions and the nature of the magnetoelectric coupling is hereafter addressed.
- Published
- 2009
- Full Text
- View/download PDF
122. O impacto das práticas de gestão do conhecimento no desempenho organizacional: um estudo em empresas de base tecnológica
- Author
-
Fabricio Ziviani, Erik Paixão Amarante, Renata de Souza França, Paulo Isnard, and Eric de Paula Ferreira
- Subjects
Knowledge ,Knowledge Management ,Organizational Performance ,high-tech enterprises ,Bibliography. Library science. Information resources - Abstract
Resumo Para que a gestão do conhecimento impacte os rumos da empresa com inovações e vantagens competitivas, é necessário integrá-la à estratégia organizacional. Apesar de existirem estudos que apontam a correlação entre gestão conhecimento, desempenho e estratégia organizacionais, a prática se torna divergente. As organizações estão cientes da importância da gestão do conhecimento, mas é preciso sair do campo do discurso e converter ações em resultados. O presente trabalho tem como objetivo avaliar o impacto das práticas de gestão do conhecimento no desempenho organizacional, através de uma pesquisa quantitativa com a aplicação de um questionário survey em empresas de base tecnológica. A pesquisa utilizou o modelo empírico de Wu e Chen, para a validação das hipóteses definidas no estudo e a técnica de modelagem de equações estruturais foi aplicada. Os resultados obtidos possibilitam confirmar as relações existentes entre as cinco dimensões analisadas- ativos do conhecimento, aprendizagem organizacional, capacidade do processo de conhecimento, capacidade do processo de negócio e desempenho organizacional-, além de identificar que dentre os construtos analisados, o processo de negócio foi o que apresentou maior influência sobre o desempenho organizacional.
- Published
- 2019
- Full Text
- View/download PDF
123. Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases
- Author
-
Romain ARRESTIER, Anne-Pascale SATIE, Shao-yu ZHANG, Emmanuelle PLAISIER, Corinne ISNARD-BAGNIS, Philippe GATAULT, Quentin RAIMBOURG, David BUOB, Flavia VOCILA, Anne-Elisabeth HENG, Helene FRANCOIS, Anissa MOKTEFI, Guillaume CANAUD, Marie MATIGNON, Nathalie DEJUCQ-RAINSFORD, Isabelle BROCHERIOU, Dil SAHALI, and Vincent AUDARD
- Subjects
Minimal change nephrotic syndrome ,HIV infection ,AIDS ,Podocytes ,Albuminuria ,C-mip ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract Background Human immunodeficiency virus (HIV) is associated with diverse glomerular diseases. Characteristics of minimal change nephrotic syndrome (MCNS) in this setting have been little studied, and the specific features of this uncommon association remain to be determined. Methods We conduct a retrospective study. Clinical, biological and pathological characteristics of patients with MCNS and HIV infection were assessed. We evaluated HIV infection by in situ hybridization and CMIP expression by immunochemistry on kidney biopsies and compared it to HIV-associated nephropathy (HIVAN) and idiopathic MCNS. Results Eight patients were identifies. In all but one of these cases, MCNS occurred after HIV diagnosis (mean of 9.5 years). Acute kidney injury was detected in three cases. Mean CD4+ lymphocyte count was 733/mm3 and three patients had a detectable HIV viral load. In situ hybridization for HIV-1 RNA detection yielded a positive signal in a few tubular cells in the renal parenchyma in two of four patients with HIV infection associated with MCNS. Podocytes of these patients presented strong positive immunostaining for CMIP (4/4). Three patients suffered steroid-dependent nephrotic syndrome, and another two patients had at least one relapse. Rituximab treatment was initiated in four cases. After a median follow-up of 20 months, all patients were in remission (complete in 5 cases). Conclusions In patients with MCNS occurring in a context of HIV infection, podocyte injury seems to be associated with CMIP induction rather than renal HIV infection but further studies are needed to determine the molecular link between these two conditions.
- Published
- 2018
- Full Text
- View/download PDF
124. Gut Leakage of Fungal‐Related Products: Turning Up the Heat for HIV Infection
- Author
-
Stéphane Isnard, John Lin, Simeng Bu, Brandon Fombuena, Léna Royston, and Jean-Pierre Routy
- Subjects
fungi ,inflammation ,HIV ,beta-D-glucan [BDG] ,immune activation ,Immunologic diseases. Allergy ,RC581-607 - Abstract
The intestinal epithelial layer serves as a physical and functional barrier between the microbiota in the lumen and immunologically active submucosa. Th17 T-cell function protects the gut epithelium from aggression from microbes and their by-products. Loss of barrier function has been associated with enhanced translocation of microbial products which act as endotoxins, leading to local and systemic immune activation. Whereas the inflammatory role of LPS produced by Gram-negative bacteria has been extensively studied, the role of fungal products such as β-D-glucan remains only partially understood. As HIV infection is characterized by impaired gut Th17 function and increased gut permeability, we critically review mechanisms of immune activation related to fungal translocation in this viral infection. Additionally, we discuss markers of fungal translocation for diagnosis and monitoring of experimental treatment responses. Targeting gut barrier dysfunction and reducing fungal translocation are emerging strategies for the prevention and treatment of HIV-associated inflammation and may prove useful in other inflammatory chronic diseases.
- Published
- 2021
- Full Text
- View/download PDF
125. POS-820 Mindfulness and compassion training for clinicians: a qualitative study
- Author
-
B. Clemence, A. Akinyemi, H. Laurene, C. Thierry, M. Claire, and C. Isnard Bagnis MD
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Published
- 2021
- Full Text
- View/download PDF
126. LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy
- Author
-
Delphine Planas, Amélie Pagliuzza, Rosalie Ponte, Augustine Fert, Laurence Raymond Marchand, Marta Massanella, Annie Gosselin, Vikram Mehraj, Franck P Dupuy, Stéphane Isnard, Jean-Philippe Goulet, Sylvie Lesage, Eric A. Cohen, Mager Peter Ghali, Jonathan B. Angel, Nicolas Chomont, Jean-Pierre Routy, and Petronela Ancuta
- Subjects
Metformin ,ART ,HIV reservoirs ,Th17 ,mTOR ,Medicine ,Medicine (General) ,R5-920 - Abstract
Background: Chronic inflammation and residual HIV transcription persist in people living with HIV (PLWH) receiving antiretroviral therapy (ART), thus increasing the risk of developing non-AIDS co-morbidities. The mechanistic target of rapamycin (mTOR) is a key regulator of cellular metabolism and HIV transcription, and therefore represents an interesting novel therapeutic target. Methods: The LILAC pilot clinical trial, performed on non-diabetic ART-treated PLWH with CD4+/CD8+ T-cell ratios
- Published
- 2021
- Full Text
- View/download PDF
127. Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitis
- Author
-
Xiaorong Peng, Stéphane Isnard, John Lin, Brandon Fombuena, Talat Bessissow, Nicolas Chomont, and Jean-Pierre Routy
- Subjects
HIV DNA ,Reservoir ,Colon ,Ulcerative colitis ,Inflammation ,Gut barrier integrity ,Microbiology ,QR1-502 ,Public aspects of medicine ,RA1-1270 - Abstract
The greatest obstacle to an HIV cure is the persistence of latently infected cellular reservoirs in people living with HIV (PLWH) taking antiretroviral therapy (ART). However, no consensus exists on the direct link between local tissue inflammation and the HIV burden. Herein, we have compared the levels of local inflammation, epithelial integrity and HIV DNA between inflamed and non-inflamed colon tissue in a PLWH who underwent a colectomy due to ulcerative colitis. We have observed a 27-fold higher frequency of cells harboring HIV DNA in inflamed compared to non-inflamed colon tissue. Analysis of the expression of occludin-1 and claudin-3 confirmed our macroscopic characterization of inflamed and non-inflamed colon. Our results confirm that increased gut permeability and inflammation are associated with a higher frequency of infected cells and suggest that restoring gut barrier integrity may be used as a strategy to reduce inflammation and HIV persistence in the gut.
- Published
- 2021
- Full Text
- View/download PDF
128. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
- Author
-
Vincent Jachiet, Guillaume Moulis, Jérome Hadjadj, Julie Seguier, Kamel Laribi, Nicolas Schleinitz, Norbert Vey, Karim Sacre, Bertrand Godeau, Odile Beyne-Rauzy, Romain Bouvet, Jonathan Broner, Natacha Brun, Thibault Comont, Clément Gaudin, Olivier Lambotte, Lenaïg Le Clech, Pierre Peterlin, Frédérique Roy-Peaud, Clémentine Salvado, Mathilde Versini, Françoise Isnard, Jean Emmanuel Kahn, Delphine Gobert, Lionel Adès, Pierre Fenaux, Olivier Fain, and Arsène Mekinian
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) are associated with systemic inflammatory or autoimmune diseases in 10-20 % of cases. Among them, immune thrombocytopenia (ITP) has been reported but large studies assessing this association are missing. Whether such patients have a particular phenotype and require particular management is unclear. This study analyzes the clinical spectrum, outcome and therapeutic management of patients with ITP associated with MDS or CMML, in comparison (i) to patients with primary ITP without MDS/CMML and (ii) to patients with MDS/CMML without ITP. Forty-one MDS/CMML-associated ITP patients were included, with chronic ITP in 26 (63%) patients, low-risk myelodysplasia in 30 (73%) patients and CMML in 24 (59%) patients. An associated autoimmune disease was noted in 10 (24%) patients. In comparison to primary ITP patients, MDS/CMML-associated ITP patients had a higher occurrence of severe bleeding despite similar platelet counts at diagnosis. First-line treatment consisted of glucocorticoids (98%) and intravenous immunoglobulin (IVIg) (56%). Response achievement with IVIg was more frequent in primary ITP than in MDS/CMML-associated ITP patients. Response rates to second-line therapies were not statistically different between primary ITP and MDS/CMMLassociated ITP patients. Ten percent (n=4) of patients with MDS/CMML-associated ITP had multirefractory ITP versus none in primary ITP controls. After a median follow-up of 60 months, there was no difference in overall survival between MDS/CMML-associated ITP and primary ITP patients. Leukemia-free-survival was significantly better in MDS/CMMLassociated ITP patients than in MDS/CMML without ITP MDS/CMML-associated ITP have a particular outcome with more severe bleeding and multirefractory profile than primary ITP, similar response profile to primary ITP therapy except for IVIg, and less progression toward acute myeloid leukemia than MDS/CMML without ITP.
- Published
- 2021
- Full Text
- View/download PDF
129. Magnetic order and spin fluctuations in the spin liquid Tb$\_2$Sn$\_2$O$\_7$
- Author
-
Mirebeau, I., Apeteri, A., Rodriguez-Carvajal, J., Bonville, P., Forget, A., Colson, D., Glazkov, V., Sanchez, J. P., Isnard, O., and Suard, E.
- Subjects
Condensed Matter - Strongly Correlated Electrons - Abstract
We have studied the spin liquid Tb$\_2$Sn$\_2$O$\_7$ by neutron diffraction and specific heat measurements. Below about 2 K, the magnetic correlations change from antiferromagnetic to ferromagnetic. Magnetic order settles in two steps, with a smeared transition at 1.3(1) K then an abrupt transition at 0.87(2) K. A new magnetic structure is observed, not predicted by current models, with both ferromagnetic and antiferromagnetic character. It suggests that the spin liquid degeneracy is lifted by dipolar interactions combined with a finite anisotropy along $<111>$ axes. In the ground state, the Tb$^{3+}$ ordered moment is reduced with respect to the free ion moment (9 $\mu\_{\rm B}$). The moment value of 3.3(3) $\mu\_{\rm B}$ deduced from the specific heat is much smaller than derived from neutron diffraction of 5.9(1) $\mu\_{\rm B}$. This difference is interpreted by the persistence of slow collective magnetic fluctuations down to the lowest temperatures.
- Published
- 2005
- Full Text
- View/download PDF
130. Successful therapeutic plasma exchange in cold autoimmune hemolytic anemia in patient with disseminated tuberculosis
- Author
-
N. Belfeki, A. Strazzulla, P. Isnard, S. Hamrouni, B. Maamar, P. Soulier, M. Monchi, and S. Diamantis
- Subjects
Autoimmune hemolytic anemia ,tuberculosis ,therapeutic plasma exchange. ,Medicine ,Internal medicine ,RC31-1245 - Abstract
An association of autoimmune hemolytic anemia with disseminated tuberculosis is an exceedingly rare entity. We describe herein a case of cold hemolytic autoimmune anemia associated with miliary tuberculosis resolved with blood transfusions, therapeutic plasma exchange, and antituberculous agents. We discuss the advantages of therapeutic plasma exchange at an early stage in the management of this condition.
- Published
- 2021
- Full Text
- View/download PDF
131. Using Experiential Learning to Teach Entrepreneurship: A Study with Brazilian Undergraduate Students
- Author
-
Krakauer, Patricia Viveiros de Castro, Serra, Fernando Antonio Ribeiro, and de Almeida, Martinho Isnard Ribeiro
- Abstract
Purpose: The purpose of this paper is to provide further understanding of entrepreneurship education, seeking to comprehend the use of experience in this context. Based on the theory of experiential learning, the authors sought to develop and test a conceptual model for teaching entrepreneurship at the undergraduate degree level. Design/methodology/approach: Due to the need to develop a model, the authors used design science research as a method to develop and test an artifact. First, bibliographic research was conducted to develop the model, which was then tested through empirical application. This empirical application was conducted at a Brazilian educational institution, with the participation of 110 students. A total of 440 activities were analyzed through content analysis. Findings: The authors found advantages and disadvantages regarding the use of experience in entrepreneurship learning, such as greater student engagement, sense of empowerment and aspects related to the course and assessments. Practical implications: In this paper, the authors offer suggestions for undergraduate teachers and to faculty members on how to teach entrepreneurship, with the student as the main actor in the learning process. Furthermore, the authors have access to a study addressing a contemporary theme that is emerging in Brazilian universities. Originality/value: In this paper, the authors contribute with the debate on entrepreneurship education, realizing that the understanding of this issue continues to require closer study due to a lack of empirical consensus in previous works. Its originality lies in the development and testing of a model for undergraduates, drawn from a theory whose main use is in graduate school.
- Published
- 2017
- Full Text
- View/download PDF
132. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
- Author
-
Xiaorong Peng, Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Biao Zhu, and Jean-Pierre Routy
- Subjects
COVID-19 ,HIV ,CD4 exhaustion ,cytokine storm ,leaky gut ,Immunologic diseases. Allergy ,RC581-607 - Abstract
COVID-19 is a distinctive infection characterized by elevated inter-human transmission and presenting from absence of symptoms to severe cytokine storm that can lead to dismal prognosis. Like for HIV, lymphopenia and drastic reduction of CD4+ T cell counts in COVID-19 patients have been linked with poor clinical outcome. As CD4+ T cells play a critical role in orchestrating responses against viral infections, important lessons can be drawn by comparing T cell response in COVID-19 and in HIV infection and by studying HIV-infected patients who became infected by SARS-CoV-2. We critically reviewed host characteristics and hyper-inflammatory response in these two viral infections to have a better insight on the large difference in clinical outcome in persons being infected by SARS-CoV-2. The better understanding of mechanism of T cell dysfunction will contribute to the development of targeted therapy against severe COVID-19 and will help to rationally design vaccine involving T cell response for the long-term control of viral infection.
- Published
- 2020
- Full Text
- View/download PDF
133. 14 Novel CD3 epsilon humanized N-terminal epitope model for assessment of efficacy of T-cell engagers
- Author
-
Gaëlle Martin, Fabiane Sônego, Audrey Beringer, Chloé Beuraud, Yacine Cherifi, Alexandre Fraichard, Patricia Isnard-Petit, and Kader Thiam
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
134. GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
- Author
-
Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Yaokai Chen, and Jean-Pierre Routy
- Subjects
metformin ,body weight ,obesity ,GDF-15 ,GFRAL ,diabetes ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Weight gain and obesity are global health concerns contributing to morbidity with increased risks of cardiovascular disease, diabetes, liver steatohepatitis and cancer. Pharmacological therapies or bariatric surgery are often required for those who fail to adhere to diet and lifestyle modifications. Metformin, a widely used antidiabetic agent, seems to have a health benefit beyond its anti-hyperglycemic properties, with few side effects. Emerging evidence shows weight loss to be associated with metformin in both diabetic and non-diabetic individuals. Recently, the growth differentiation factor 15 (GDF-15), a member of the transforming growth factor beta superfamily, has been identified as a key mediator of metformin-induced weight loss. Metformin increases the secretion of GDF-15, which binds exclusively to glial cell-derived neurotrophic factor family receptor alpha-like (GFRAL). This gut-brain cytokine works as a prominent player in reducing food intake and body weight in health and disease, like anorexia nervosa and cancer. Herein, we critically review advances in the understanding of the weight-reducing effects of metformin via the GDF-15 pathway.
- Published
- 2020
- Full Text
- View/download PDF
135. Phenotype of Mrps5-Associated Phylogenetic Polymorphisms Is Intimately Linked to Mitoribosomal Misreading
- Author
-
Reda Juskeviciene, Ann-Kristina Fritz, Margarita Brilkova, Rashid Akbergenov, Karen Schmitt, Hubert Rehrauer, Endre Laczko, Patricia Isnard-Petit, Kader Thiam, Anne Eckert, Jochen Schacht, David P. Wolfer, Erik C. Böttger, and Dimitri Shcherbakov
- Subjects
point mutation ,mitoribosomal protein ,misreading ,mitochondria ,protein synthesis ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
We have recently identified point mutation V336Y in mitoribosomal protein Mrps5 (uS5m) as a mitoribosomal ram (ribosomal ambiguity) mutation conferring error-prone mitochondrial protein synthesis. In vivo in transgenic knock-in animals, homologous mutation V338Y was associated with a discrete phenotype including impaired mitochondrial function, anxiety-related behavioral alterations, enhanced susceptibility to noise-induced hearing damage, and accelerated metabolic aging in muscle. To challenge the postulated link between Mrps5 V338Y-mediated misreading and the in vivo phenotype, we introduced mutation G315R into the mouse Mrps5 gene as Mrps5 G315R is homologous to the established bacterial ram mutation RpsE (uS5) G104R. However, in contrast to bacterial translation, the homologous G → R mutation in mitoribosomal Mrps5 did not affect the accuracy of mitochondrial protein synthesis. Importantly, in the absence of mitochondrial misreading, homozygous mutant MrpS5G315R/G315R mice did not show a phenotype distinct from wild-type animals.
- Published
- 2022
- Full Text
- View/download PDF
136. Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France
- Author
-
Eric Farfour, Laurent Dortet, Thomas Guillard, Nicolas Chatelain, Agathe Poisson, Assaf Mizrahi, Damien Fournier, Rémy A. Bonnin, Nicolas Degand, Philippe Morand, Frédéric Janvier, Vincent Fihman, Stéphane Corvec, Lauranne Broutin, Cécile Le Brun, Nicolas Yin, Geneviève Héry-Arnaud, Antoine Grillon, Emmanuelle Bille, Hélène Jean-Pierre, Marlène Amara, Francoise Jaureguy, Christophe Isnard, Vincent Cattoir, Tristan Diedrich, Emilie Flevin, Audrey Merens, Hervé Jacquier, Marc Vasse, and on behalf of the GMC Study Group
- Subjects
Enterobacterales ,ESBL ,urinary tract infection (UTI) ,fosfomycin ,carbapenem ,temocillin ,Medicine - Abstract
In the context of increasing antimicrobial resistance in Enterobacterales, the management of these UTIs has become challenging. We retrospectively assess the prevalence of antimicrobial resistance in Enterobacterales isolates recovered from urinary tract samples in France, between 1 September 2017, to 31 August 2018. Twenty-six French clinical laboratories provided the susceptibility of 134,162 Enterobacterales isolates to 17 antimicrobials. The most frequent species were E. coli (72.0%), Klebsiella pneumoniae (9.7%), Proteus mirabilis (5.8%), and Enterobacter cloacae complex (2.9%). The overall rate of ESBL-producing Enterobacterales was 6.7%, and ranged from 1.0% in P. mirabilis to 19.5% in K. pneumoniae, and from 3.1% in outpatients to 13.6% in long-term care facilities. Overall, 4.1%, 9.3% and 10.5% of the isolates were resistant to cefoxitin, temocillin and pivmecillinam. Cotrimoxazole was the less active compound with 23.4% resistance. Conversely, 4.4%, 12.9%, and 14.3% of the strains were resistant to fosfomycin, nitrofurantoin, and ciprofloxacin. However, less than 1% of E. coli was resistant to fosfomycin and nitrofurantoin. We identified several trends in antibiotics resistances among Enterobacterales isolates recovered from the urinary tract samples in France. Carbapenem-sparing drugs, such as temocillin, mecillinam, fosfomycin, cefoxitin, and nitrofurantoin, remained highly active, including towards ESBL-E.
- Published
- 2022
- Full Text
- View/download PDF
137. Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers
- Author
-
Stéphane Isnard, Léna Royston, John Lin, Brandon Fombuena, Simeng Bu, Sanket Kant, Tsoarello Mabanga, Carolina Berini, Mohamed El-Far, Madeleine Durand, Cécile L. Tremblay, Nicole F. Bernard, Guido Kroemer, and Jean-Pierre Routy
- Subjects
elite controllers ,HIV ,acyl-coA-binding protein ,autophagy ,Microbiology ,QR1-502 - Abstract
HIV elite controllers (ECs) are characterized by the spontaneous control of viral replication, and by metabolic and autophagic profiles which favor anti-HIV CD4 and CD8 T-cell responses. Extracellular acyl coenzyme A binding protein (ACBP) acts as a feedback inhibitor of autophagy. Herein, we assessed the circulating ACBP levels in ECs, compared to people living with HIV (PLWH) receiving antiretroviral therapy (ART) or not. We found lower ACBP levels in ECs compared to ART-naïve or ART-treated PLWH (p < 0.01 for both comparisons), independently of age and sex. ACBP levels were similar in ECs and HIV-uninfected controls. The expression of the protective HLA alleles HLA-B*27, *57, or *58 did not influence ACBP levels in ECs. ACBP levels were not associated with CD4 or CD8 T-cell counts, CD4 loss over time, inflammatory cytokines, or anti-CMV IgG titers in ECs. In ART-treated PLWH, ACBP levels were correlated with interleukin (IL)-1β levels, but not with other inflammatory cytokines such as IL-6, IL-8, IL-32, or TNF-α. In conclusion, ECs are characterized by low ACBP plasma levels compared to ART-naïve or ART-treated PLWH. As autophagy is key to anti-HIV CD4 and CD8 T-cell responses, the ACBP pathway constitutes an interesting target in HIV cure strategies.
- Published
- 2022
- Full Text
- View/download PDF
138. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial
- Author
-
Maggioni, AP, Greene, SJ, Fonarow, GC, Bohm, M, Zannad, F, Solomon, SD, Lewis, EF, Baschiera, F, Hua, TA, Gimpelewicz, CR, Lesogor, A, Gheorghiade, M, Ramos, S, Luna, A, Miriuka, S, Diez, M, Perna, E, Luquez, H, Pinna, JG, Castagnino, J, Alvarenga, P, Ibanez, J, Blumberg, ES, Dizeo, C, Guerrero, RA, Schygiel, P, Milesi, R, Sosa, C, Hominal, M, Marquez, LL, Poy, C, Hasbani, E, Vico, M, Fernandez, A, Vita, N, Vanhaecke, J, De Keulenaer, G, Striekwold, H, Vervoort, G, Vrolix, M, Henry, P, Dendale, P, Smolders, W, Marechal, P, Vandekerckhove, H, Oliveira, M, Neuenschwande, F, Reis, G, Saraiva, J, Bodanese, L, Canesin, M, Greco, O, Bassan, R, Marino, RL, Giannetti, N, Moe, G, Sussex, B, Sheppard, R, Huynh, T, Stewart, R, Haddad, H, Echeverria, L, Quintero, A, Torres, A, Jaramillo, M, Lopez, M, Mendoza, F, Florez, N, Cotes, C, Garcia, M, Belohlavek, J, Hradec, J, Peterka, M, Gregor, P, Monhart, Z, Jansky, P, Kettner, J, Reichert, P, Spinar, J, Brabec, T, Hutyra, M, Solar, M, Pietila, M, Nyman, K, Pajari, R, Cohen, A, Galinier, M, Gosse, P, Livarek, B, Neuder, Y, Jourdain, P, Picard, F, Isnard, R, Hoppe, U, Kaeaeb, S, Rosocha, S, Prondzinsky, R, Felix, S, Duengen, H-D, and Figulla, H-R
- Subjects
Heart Disease ,Clinical Research ,Clinical Trials and Supportive Activities ,Diabetes ,Cardiovascular ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Metabolic and endocrine ,Administration ,Oral ,Amides ,Cardiotonic Agents ,Death ,Sudden ,Cardiac ,Diabetic Cardiomyopathies ,Double-Blind Method ,Female ,Fumarates ,Heart Failure ,Hospitalization ,Humans ,Kaplan-Meier Estimate ,Male ,Middle Aged ,Prospective Studies ,Renin ,Treatment Outcome ,Aliskiren ,Outcomes ,Post-discharge ,ASTRONAUT Investigators and Coordinators ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Cardiovascular System & Hematology - Abstract
AimsThe objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in patients with and without baseline diabetes mellitus (DM).Methods and resultsASTRONAUT included 953 patients without DM (aliskiren 489; placebo 464) and 662 patients with DM (aliskiren 319; placebo 343) (as reported by study investigators). Study endpoints included the first occurrence of cardiovascular death or HHF within 6 and 12 months, all-cause death within 6 and 12 months, and change from baseline in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 1, 6, and 12 months. Data regarding risk of hyperkalaemia, renal impairment, and hypotension, and changes in additional serum biomarkers were collected. The effect of aliskiren on cardiovascular death or HHF within 6 months (primary endpoint) did not significantly differ by baseline DM status (P = 0.08 for interaction), but reached statistical significance at 12 months (non-DM: HR: 0.80, 95% CI: 0.64-0.99; DM: HR: 1.16, 95% CI: 0.91-1.47; P = 0.03 for interaction). Risk of 12-month all-cause death with aliskiren significantly differed by the presence of baseline DM (non-DM: HR: 0.69, 95% CI: 0.50-0.94; DM: HR: 1.64, 95% CI: 1.15-2.33; P < 0.01 for interaction). Among non-diabetics, aliskiren significantly reduced NT-proBNP through 6 months and plasma troponin I and aldosterone through 12 months, as compared to placebo. Among diabetic patients, aliskiren reduced plasma troponin I and aldosterone relative to placebo through 1 month only. There was a trend towards differing risk of post-baseline potassium ≥6 mmol/L with aliskiren by underlying DM status (non-DM: HR: 1.17, 95% CI: 0.71-1.93; DM: HR: 2.39, 95% CI: 1.30-4.42; P = 0.07 for interaction).ConclusionThis pre-specified subgroup analysis from the ASTRONAUT trial generates the hypothesis that the addition of aliskiren to standard HHF therapy in non-diabetic patients is generally well-tolerated and improves post-discharge outcomes and biomarker profiles. In contrast, diabetic patients receiving aliskiren appear to have worse post-discharge outcomes. Future prospective investigations are needed to confirm potential benefits of renin inhibition in a large cohort of HHF patients without DM.
- Published
- 2013
139. Geobotany in a fault in the world’s largest continuous wetland in central South America
- Author
-
de Almeida, Teodoro Isnard Ribeiro, do Amaral, Cibele Hummel, Botelho, Moreno, Ribeiro, Eduardo Francisco, and Penatti, Natasha Costa
- Published
- 2019
- Full Text
- View/download PDF
140. Twenty years after Jaffré et al. (1998), is the system of protected areas now adequate in New Caledonia?
- Author
-
Ibanez, Thomas, Birnbaum, Philippe, Gâteblé, Gildas, Hequet, Vanessa, Isnard, Sandrine, Munzinger, Jérôme, Pillon, Yohan, Pouteau, Robin, Vandrot, Hervé, and Jaffré, Tanguy
- Published
- 2019
- Full Text
- View/download PDF
141. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
- Author
-
Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Jean-Pierre Routy, and Yaokai Chen
- Subjects
coronavirus disease 2019 ,severe acute respiratory syndrome coronavirus-2 ,convalescent plasma therapy ,immunotherapy ,antibody ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Coronavirus disease 2019 (COVID-19) is a pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Most infected people have mild or moderate symptoms and recover without the need for extensive treatment. However, for seriously ill patients, no specific treatments are currently available. Convalescent plasma therapy (CPT), a passive immunotherapy, involves infusing plasma from recovered people into actively infected people, and is thought to be a specific intervention to improve outcome in patients with severe COVID-19. The presumed mechanism involves neutralizing antibodies and antibody dependent cytotoxicity/phagocytosis. Previous CPT trials showed an effect in SARS and pilot studies suggest CPT is an effective and safe strategy for seriously ill COVID-19 patients. CPT is currently being tested in large randomized clinical trials. Herein, we critically review the mechanism, applications and the challenges for CPT in the treatment of severe COVID-19, paving the way toward vaccine and immunotherapy development.
- Published
- 2020
- Full Text
- View/download PDF
142. Novel Insights Into the Hyperaccumulation Syndrome in Pycnandra (Sapotaceae)
- Author
-
Sandrine Isnard, Laurent L’Huillier, Adrian L. D. Paul, Jérôme Munzinger, Bruno Fogliani, Guillaume Echevarria, Peter D. Erskine, Vidiro Gei, Tanguy Jaffré, and Antony van der Ent
- Subjects
hydroponic ,hyperaccumulation ,laticifers ,nickel ,Pycnandra ,X-ray fluorescence spectroscopy ,Plant culture ,SB1-1110 - Abstract
The discovery of nickel hyperaccumulation, in Pycnandra acuminata, was the start of a global quest in this fascinating phenomenon. Despite recent advances in the physiology and molecular genetics of hyperaccumulation, the mechanisms and tolerance of Ni accumulation in the most extreme example reported to date, P. acuminata, remains enigmatic. We conducted a hydroponic experiment to establish Ni tolerance levels and translocation patterns in roots and shoots of P. acuminata, and analyzed elemental partitioning to gain insights into Ni regulation. We combined a phylogeny and foliar Ni concentrations to assess the incidence of hyperaccumulation within the genus Pycnandra. Hydroponic dosing experiments revealed that P. acuminata can resist extreme Ni concentrations in solution (up to 3,000 µM), and dosing at 100 µM Ni was beneficial to growth. All plant parts were highly enriched in Ni, but the latex had extreme Ni concentrations (124,000 µg g−1). Hyperaccumulation evolved independently in only two subgenera and five species of the genus Pycnandra. The extremely high level of Ni tolerance is posited to derive from the unique properties of laticifers. The evolutionary and ecological significance of Ni hyperaccumulation in Pycnandra is discussed in light of these findings. We suggest that Ni-rich laticifers might be more widespread in the plant kingdom and that more investigation is warranted.
- Published
- 2020
- Full Text
- View/download PDF
143. Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
- Author
-
Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Seema Nair Parvathy, Yaokai Chen, Michael S. Silverman, and Jean-Pierre Routy
- Subjects
fecal microbiota transplantation ,graft-vs.-host disease ,HIV infection ,gut epithelial damage ,dysbiosis ,Medicine (General) ,R5-920 - Abstract
The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulatory functions. Dysregulation of the gut microbiota composition, termed dysbiosis, has been associated with epithelial damage and translocation of microbial products into the circulating blood. Dysbiosis, increased gut permeability and chronic inflammation play a major role on the clinical outcome of inflammatory bowel diseases, graft-vs.-host disease (GVHD) and HIV infection. In this review, we focus on GVHD and HIV infection, conditions sharing gut immune damage leading to dysbiosis. The degree of dysbiosis and level of epithelial gut damage predict poor clinical outcome in both conditions. Emerging interventions are therefore warranted to promote gut microbiota homeostasis and improve intestinal barrier function. Interventions such as anti-inflammatory medications, and probiotics have toxicity and/or limited transitory effects, justifying innovative approaches. Fecal microbiota transplantation (FMT) is one such approach where fecal microorganisms are transferred from healthy donors into the GI tract of the recipient to restore microbiota composition in patients with Clostridium difficile-induced colitis or inflammatory bowel diseases. Preliminary findings point toward a beneficial effect of FMT to improve GVHD and HIV-related outcomes through the engraftment of beneficial donor bacteria, notably those producing anti-inflammatory metabolites. Herein, we critically review the potential for FMT in alleviating dysbiosis and gut damage in patients with GVHD or HIV-infection. Understanding the underlying mechanism by which FMT restores gut function will pave the way toward novel scalable and targeted interventions.
- Published
- 2020
- Full Text
- View/download PDF
144. Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection
- Author
-
Marco Iannetta, Stéphane Isnard, Jennifer Manuzak, Jean-Baptiste Guillerme, Mathilde Notin, Karine Bailly, Muriel Andrieu, Sonia Amraoui, Lene Vimeux, Suzanne Figueiredo, Bénédicte Charmeteau-de Muylder, Laura Vaton, Etienne X. Hatton, Assia Samri, Brigitte Autran, Rodolphe Thiébaut, Nathalie Chaghil, David Glohi, Charlotte Charpentier, Diane Descamps, Françoise Brun-Vézinet, Sophie Matheron, Remi Cheynier, and Anne Hosmalin
- Subjects
HIV-2 ,monocytes ,slan+ monocytes ,dendritic cells ,cDC1 ,cDC2 ,Immunologic diseases. Allergy ,RC581-607 - Abstract
HIV-2 infection is characterized by low viremia and slow disease progression as compared to HIV-1 infection. Circulating CD14++CD16+ monocytes were found to accumulate and CD11c+ conventional dendritic cells (cDC) to be depleted in a Portuguese cohort of people living with HIV-2 (PLWHIV-2), compared to blood bank healthy donors (HD). We studied more precisely classical monocytes; CD16+ inflammatory (intermediate, non-classical and slan+ monocytes, known to accumulate during viremic HIV-1 infection); cDC1, important for cross-presentation, and cDC2, both depleted during HIV-1 infection. We analyzed by flow cytometry these PBMC subsets from Paris area residents: 29 asymptomatic, untreated PLWHIV-2 from the IMMUNOVIR-2 study, part of the ANRS-CO5 HIV-2 cohort: 19 long-term non-progressors (LTNP; infection ≥8 years, undetectable viral load, stable CD4 counts≥500/μL; 17 of West-African origin -WA), and 10 non-LTNP (P; progressive infection; 9 WA); and 30 age-and sex-matched controls: 16 blood bank HD with unknown geographical origin, and 10 HD of WA origin (GeoHD). We measured plasma bacterial translocation markers by ELISA. Non-classical monocyte counts were higher in GeoHD than in HD (54 vs. 32 cells/μL, p = 0.0002). Slan+ monocyte counts were twice as high in GeoHD than in HD (WA: 28 vs. 13 cells/μL, p = 0.0002). Thus cell counts were compared only between participants of WA origin. They were similar in LTNP, P and GeoHD, indicating that there were no HIV-2 related differences. cDC counts did not show major differences between the groups. Interestingly, inflammatory monocyte counts correlated with plasma sCD14 and LBP only in PLWHIV-2, especially LTNP, and not in GeoHD. In conclusion, in LTNP PLWHIV-2, inflammatory monocyte counts correlated with LBP or sCD14 plasma levels, indicating a potential innate immune response to subclinical bacterial translocation. As GeoHD had higher inflammatory monocyte counts than HD, our data also show that specific controls are important to refine innate immunity studies.
- Published
- 2020
- Full Text
- View/download PDF
145. COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study
- Author
-
Echeverría, Patricia, Mas Bergas, Miquel Angel, Puig, Jordi, Isnard, Mar, Massot, Mireia, Vedia, Cristina, Peiró, Ricardo, Ordorica, Yolanda, Pablo, Sara, Ulldemolins, María, Iruela, Mercé, Balart, Dolors, Ruiz, José María, Herms, Jordi, Clotet Sala, Bonaventura, and Negredo, Eugenia
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
BackgroundThe coronavirus disease (COVID-19) pandemic has caused an unprecedented worldwide public health crisis that requires new management approaches. COVIDApp is a mobile app that was adapted for the management of institutionalized individuals in long-term care facilities. ObjectiveThe aim of this paper is to report the implementation of this innovative tool for the management of long-term care facility residents as a high-risk population, specifically for early identification and self-isolation of suspected cases, remote monitoring of mild cases, and real-time monitoring of the progression of the infection. MethodsCOVIDApp was implemented in 196 care centers in collaboration with 64 primary care teams. The following parameters of COVID-19 were reported daily: signs/symptoms; diagnosis by reverse transcriptase–polymerase chain reaction; absence of symptoms for ≥14 days; total deaths; and number of health care workers isolated with suspected COVID-19. The number of at-risk centers was also described. ResultsData were recorded from 10,347 institutionalized individuals and up to 4000 health care workers between April 1 and 30, 2020. A rapid increase in suspected cases was seen until day 6 but decreased during the last two weeks (from 1084 to 282 cases). The number of confirmed cases increased from 419 (day 6) to 1293 (day 22) and remained stable during the last week. Of the 10,347 institutionalized individuals, 5,090 (49,2%) remained asymptomatic for ≥14 days. A total of 854/10,347 deaths (8.3%) were reported; 383 of these deaths (44.8%) were suspected/confirmed cases. The number of isolated health care workers remained high over the 30 days, while the number of suspected cases decreased during the last 2 weeks. The number of high-risk long-term care facilities decreased from 19/196 (9.5%) to 3/196 (1.5%). ConclusionsCOVIDApp can help clinicians rapidly detect and remotely monitor suspected and confirmed cases of COVID-19 among institutionalized individuals, thus limiting the risk of spreading the virus. The platform shows the progression of infection in real time and can aid in designing new monitoring strategies.
- Published
- 2020
- Full Text
- View/download PDF
146. Landscape of in vivo Fitness-Associated Genes of Enterobacter cloacae Complex
- Author
-
François Guérin, Claire Lallement, Benoit Goudergues, Christophe Isnard, Maurizio Sanguinetti, Margherita Cacaci, Riccardo Torelli, Vincent Cattoir, and Jean-Christophe Giard
- Subjects
E. cloacae ,Tn-seq ,fitness ,virulence ,pathogenicity ,Microbiology ,QR1-502 - Abstract
Species of the Enterobacter cloacae complex (ECC) represent an increasing cause of hospital-acquired infections and commonly exhibit multiple antibiotic resistances. In order to identify genes that may play a role in its ability to colonize the host, we used the transposon-sequencing (Tn-seq) approach. To this end, a high-density random transposon insertion library was obtained from E. cloacae subsp. cloacae ATCC 13047, which was used to analyze the fitness of ca. 300,000 mutants in Galleria mellonella colonization model. Following massively parallel sequencing, we identified 624 genes that seemed essential for the optimal growth and/or the fitness within the host. Moreover, 63 genes where mutations resulted in positive selection were found, while 576 genes potentially involved in the in vivo fitness were observed. These findings pointed out the role of some transcriptional regulators, type VI secretion system, and surface-associated proteins in the in vivo fitness of E. cloacae ATCC 13047. We then selected eight genes based on their high positive or negative fold changes (FCs) and tested the corresponding deletion mutants for their virulence and ability to cope with stresses. Thereby, we showed that ECL_02247 (encoding the NAD-dependent epimerase/dehydratase) and ECL_04444 (coding for a surface antigen-like protein) may correspond to new virulence factors, and that the regulator ECL_00056 was involved in in vivo fitness. In addition, bacterial cells lacking the flagellum-specific ATP synthase FliI (ECL_03223) and the hypothetical protein ECL_01421 were affected for mobility and resistance to H2O2, respectively. All these results yield valuable information regarding genes important for infection process and stress response of E. cloacae ATCC 13047 and participate to a better understanding of the opportunistic traits in this bacterial pathogen.
- Published
- 2020
- Full Text
- View/download PDF
147. Adenovirus-induced Erythema Multiforme: Eye and Genital Mucosal Involvement is Specific, Whereas Oral and Cutaneous Involvement is Not
- Author
-
Albane Calas, Coralie Lheure, Charlotte Bernigaud, Jean-François Meritet, Pierre Sohier, Jérémy Augustin, Camille Isnard, Nathalie Franck, Gerard Royer, Saskia Ingen-Housz-Oro, and Nicolas Dupin
- Subjects
adenovirus ,conjunctivitis ,erythema multiforme ,Dermatology ,RL1-803 - Abstract
Abstract is missing (Short communication)
- Published
- 2020
- Full Text
- View/download PDF
148. The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
- Author
-
Jing Ouyang, John Lin, Stéphane Isnard, Brandon Fombuena, Xiaorong Peng, André Marette, Bertrand Routy, Meriem Messaoudene, Yaokai Chen, and Jean-Pierre Routy
- Subjects
Akkermansia muciniphila ,epithelial gut damage ,inflammation ,microbial translocation ,HIV ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Gut dysbiosis, namely dysregulation of the intestinal microbiota, and increased gut permeability lead to enhanced inflammation and are commonly seen in chronic conditions such as obesity and aging. In people living with HIV (PLWH), several lines of evidence suggest that a depletion of gut CD4 T-cells is associated with gut dysbiosis, microbial translocation and systemic inflammation. Antiretroviral therapy (ART) rapidly controls viral replication, which leads to CD4 T-cell recovery and control of the disease. However, gut dysbiosis, epithelial damage and microbial translocation persist despite ART, increasing risk of developing inflammatory non-AIDS comorbidities such as cardiovascular disease, diabetes mellitus, liver steatosis and cancer. In addition to ART, an emerging research priority is to discover strategies to improve the gut microbial composition and intestinal barrier function. Probiotic interventions have been extensively used with controversial benefits in humans. Encouragingly, within the last decade, the intestinal symbiotic bacterium Akkermansia muciniphila has emerged as the “sentinel of the gut.” A lower abundance of A. muciniphila has been shown in diabetic and obese people as well as in PLWH. Interventions with high levels of polyphenols such as tea or diets rich in fruit, the antibiotic vancomycin and the antidiabetic drug metformin have been shown to increase A. muciniphila abundance, contributing to improved metabolic function in diabetic and obese individuals. We hypothesize that gut microbiota rich in A. muciniphila can reduce microbial translocation and inflammation, preventing occurrences of non-AIDS comorbidities in PLWH. To this aim, we will discuss the protective effect of A. muciniphila and its potential applications, paving the way toward novel therapeutic strategies to improve gut health in PLWH.
- Published
- 2020
- Full Text
- View/download PDF
149. Peculiarity of a magnetic structure in a quasi-one-dimensional columbite Co0.4Ni0.6Nb2O6
- Author
-
P. W. C. Sarvezuk, J. B. M. da Cunha, and O. Isnard
- Subjects
Physics ,QC1-999 - Abstract
Quasi-one-dimensional (Q1D) spin chain systems have great potential applications in high-density information storage devices, quantum information and computers, because of their quantum magnetism properties. The low-dimensional magnetic behavior has been investigated in ANb2O6, (A = Mn, Fe, Co or Ni) compounds, the structural and magnetic properties are very interesting because the system presents weakly interacting Ising chains, which leads to this quasi-one-dimensional magnetic order. Our investigation combines specific heat and magnetic measurements; x-ray and neutron diffraction (ND). In this work, we present a Co/Ni orthorhombic structure, called columbite, which crystallizes with Pbcn space group, whose formula is Co0.4Ni0.6Nb2O6. Co for Ni substitution induces a continuous lattice volume decrease, preserving the orthorhombic crystal structure. Magnetic susceptibility and specific heat measurements reveal that antiferromagnetic order occurs at 3.4 K, as a consequence of weak interchain interactions. Partial substitution of the magnetic ion tends to change the magnetic ordering observed in the CoNb2O6 and NiNb2O6. Lastly, we present this magnetic structure changes with the Ni-Co substitution.
- Published
- 2020
- Full Text
- View/download PDF
150. Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection
- Author
-
Gwenoline Borhis, Maria Trovato, Hany M. Ibrahim, Stephane Isnard, Roger Le Grand, Nathalie Bosquet, and Yolande Richard
- Subjects
B-cells ,BAFF ,GC ,TFH ,memory B-cells ,SIV ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Memory B-cell dysfunctions and inefficient antibody response suggest germinal center (GC) impairments during HIV/SIV infection with possible contribution of overproduced B-cell activating factor (BAFF). To address this question, we compared proportions and functions of various B-cell subsets and follicular helper T-cells (TFH) in untreated (Placebo) and BR3-Fc treated (Treated) SIV-infected macaques. From day 2 post-infection (dpi), Treated macaques received one weekly injection of BR3-Fc molecule, a soluble BAFF antagonist, for 4 weeks. Whereas, the kinetics of CD4+ T-cell loss and plasma viral loads were comparable in both groups, BAFF blockade delayed the peak of inflammatory cytokines (CXCL10, IFNα), impaired the renewal of plasmacytoid dendritic cells and fostered the decline of plasma CXCL13 titers after 14 dpi. In Treated macaques, proportions of total and naïve B-cells were reduced in blood and spleen whereas SIV-induced loss of marginal zone (MZ) B-cells was only accentuated in blood and terminal ileum. Proportions of spleen GC B-cells and TFH were similar in both groups, with CD8+ T-cells and rare Foxp3+ being present in spleen GC. Regardless of treatment, sorted TFH produced similar levels of IL21, CXCL13, and IFNγ but no IL2, IL4, or BAFF and exhibited similar capacities to support IgG production by autologous or heterologous B-cells. Consistently, most TFH were negative for BAFF-R and TACI. Higher proportions of resting and atypical (CD21lo) memory B-cells were present in Treated macaques compared to Placebo. In both groups, we found higher levels of BAFF-R expression on MZ and resting memory B-cells but low levels on atypical memory B-cells. TACI was present on 20-30% of MZ, resting and atypical memory B-cells in Placebo macaques. BAFF blockade decreased TACI expression on these B-cell subsets as well as titers of SIV-specific and vaccine-specific antibodies arguing for BAFF being mandatory for plasma cell survival. Irrespective of treatment, GC B-cells expressed BAFF-R at low level and were negative for TACI. In addition to key information on spleen BAFF-R and TACI expression, our data argue for BAFF contributing to the GC reaction in terminal ileum but being dispensable for the generation of atypical memory B-cells and GC reaction in spleen during T-dependent response against SIV.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.